epirubicin and Disease Models, Animal

Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection

Topics: Amines; Animals; Cell Differentiation; Cell Line, Tumor; Disease Models, Animal; Drug Liberation; Epirubicin; Feasibility Studies; Humans; Immunotherapy; Liposomes; Macrophages; Male; Mice; Monocytes; N-Acetylneuraminic Acid; Nanoconjugates; Neoplasms; Rats; RAW 264.7 Cells; Sialic Acid Binding Immunoglobulin-like Lectins; Tissue Distribution; Tumor Microenvironment

Topics: Animals; Biomarkers; Cardiotoxicity; Disease Models, Animal; Early Diagnosis; Echocardiography, Doppler, Color; Echocardiography, Doppler, Pulsed; Epirubicin; Heart Diseases; Male; Mice, Inbred BALB C; Myocardial Contraction; Myocardium; Observer Variation; Predictive Value of Tests; Reproducibility of Results; Time Factors; Troponin I; Ventricular Function, Left

Topics: Analgesics; Animals; Antineoplastic Agents; Disease Models, Animal; Docetaxel; Duloxetine Hydrochloride; Epirubicin; Female; Neoadjuvant Therapy; Neuralgia; Pain; Pain Measurement; Peripheral Nervous System Diseases; Pregnanolone; Sciatic Nerve

Topics: Aldehyde-Lyases; Animals; Autophagy; Cell Membrane Permeability; Cells, Cultured; Disease Models, Animal; Down-Regulation; Epirubicin; Extracellular Signal-Regulated MAP Kinases; Humans; Mice; Mucin-1; p38 Mitogen-Activated Protein Kinases; Prospective Studies; Pulmonary Surfactant-Associated Protein D; Random Allocation; Sepsis; Sphingosine-1-Phosphate Receptors; Treatment Outcome

Topics: Animals; Cell Line, Tumor; Cell Movement; Cyclophosphamide; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Therapy; Epirubicin; Epithelial-Mesenchymal Transition; Female; Humans; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Paclitaxel; Triple Negative Breast Neoplasms; Vimentin; Zebrafish

Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Disease Models, Animal; Drug Therapy, Combination; Epirubicin; Gliosarcoma; Humans; Hydrogels; Infusion Pumps, Implantable; Magnetic Resonance Imaging; Mice; Neoplasm, Residual; Paclitaxel; Secondary Prevention; Survival Analysis; Treatment Outcome; Tumor Cells, Cultured

Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Biomarkers; Carcinoma, Hepatocellular; Celecoxib; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Synergism; Epirubicin; Humans; Immunomodulation; Liver Neoplasms, Experimental; Rats; Topoisomerase II Inhibitors; Treatment Outcome; Xenograft Model Antitumor Assays

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aptamers, Peptide; Calcium Carbonate; Cell Line, Tumor; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Drug Screening Assays, Antitumor; Drug Synergism; Epirubicin; Female; Humans; Melitten; Mice; Mice, Inbred BALB C; Mucin-1; Nanoparticles; Neoplasms; Treatment Outcome

Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell-Penetrating Peptides; Disease Models, Animal; Drug Carriers; Epirubicin; Humans; Mice, Nude; Optical Imaging; Organometallic Compounds; Positron-Emission Tomography; Staining and Labeling; Virosomes

Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cardiotoxicity; Cell Survival; Chitosan; Disease Models, Animal; Drug Delivery Systems; Epirubicin; Glutathione; Heart; Hep G2 Cells; Hepatocytes; Humans; Lactic Acid; Lipid Peroxidation; Liver; Liver Neoplasms; Mice; Nanoparticles; Neovascularization, Pathologic; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Superoxide Dismutase; Tocotrienols; Tumor Suppressor Protein p53

Topics: Adult; Aged; Animals; Carcinoma, Hepatocellular; Cell Hypoxia; Chemoembolization, Therapeutic; Disease Models, Animal; Disease Progression; Epirubicin; Female; Fibrosis; Fluorouracil; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Infusions, Intra-Arterial; Liver; Liver Cirrhosis, Experimental; Liver Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Rats, Sprague-Dawley

Topics: Animals; Antibiotics, Antineoplastic; Cryosurgery; Disease Models, Animal; Drug Compounding; Epirubicin; Ethanol; Injections, Intralesional; Neoplasms; Rabbits; Solutions; Tomography, X-Ray Computed; Triiodobenzoic Acids

Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Checkpoint Kinase 1; Disease Models, Animal; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Endonucleases; Epirubicin; Gene Knockdown Techniques; Genetic Vectors; Humans; Lentivirus; Liver Neoplasms; Mice; Mice, Knockout; Protein Kinase Inhibitors; Protein Kinases; RNA, Small Interfering; S Phase Cell Cycle Checkpoints; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays

Topics: Administration, Intravesical; Animals; Antibiotics, Antineoplastic; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Epirubicin; Epithelium; Hydrogel, Polyethylene Glycol Dimethacrylate; Permeability; Rats; Signal Transduction; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays

Topics: Animals; Autophagy; Cardiotonic Agents; Cardiotoxicity; Collagen; Disease Models, Animal; Drugs, Chinese Herbal; Epirubicin; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Gene Expression Regulation; Heart Diseases; Hypertrophy, Left Ventricular; Male; Matrix Metalloproteinase 9; Myocardium; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Stroke Volume; Time Factors; Tissue Inhibitor of Metalloproteinase-4; Tissue Inhibitor of Metalloproteinases; Transforming Growth Factor beta1; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling

Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Delivery Systems; Epirubicin; Female; Glioma; Humans; Polymers; Rats; Rats, Inbred F344; Tetrazolium Salts; Thiazoles; Time Factors

Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Cell Transplantation; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Epirubicin; Feasibility Studies; Immunocompetence; Liver Neoplasms; Rats; Rats, Sprague-Dawley; Ultrasonography

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Disease Models, Animal; Drug Carriers; Epirubicin; Female; Liposomes; Mice; Neoplasm Transplantation; Neoplasms; Rats; Rats, Sprague-Dawley; Temperature; Treatment Outcome

Topics: Adenoviridae; Adult; Animals; Antibiotics, Antineoplastic; Antibodies, Viral; Arthritis, Experimental; Combined Modality Therapy; Disease Models, Animal; Epirubicin; Female; Fibroblasts; Gene Expression; Gene Targeting; Genetic Therapy; Genetic Vectors; Humans; Male; Mice; Mice, Inbred DBA; Middle Aged; Recombinant Proteins; Synovial Membrane; TNF-Related Apoptosis-Inducing Ligand

Topics: Animals; Cell Death; Disease Models, Animal; Epirubicin; Female; Hydrolysis; Mammary Neoplasms, Experimental; Mice

Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cell Line, Tumor; Cell Survival; Cyclophosphamide; Deoxycytidine; Disease Models, Animal; DNA, Neoplasm; Docetaxel; Doxorubicin; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Epirubicin; Female; Floxuridine; Gemcitabine; Gene Expression Regulation, Neoplastic; Guanine Nucleotide Exchange Factors; Humans; Mice; Mice, Nude; Neoplastic Stem Cells; Paclitaxel; Proto-Oncogene Proteins; Receptor, ErbB-2; Taxoids; Transplantation, Heterologous; Trastuzumab; Tumor Stem Cell Assay; Up-Regulation; Vinblastine; Vinorelbine

Topics: Adipose Tissue; alpha-Tocopherol; Animals; Anthracyclines; Antibiotics, Antineoplastic; Antioxidants; Carcinogens; Diet; Disease Models, Animal; Drug Antagonism; Drug Resistance, Neoplasm; Epirubicin; Fatty Acids, Unsaturated; Female; Fish Oils; Malondialdehyde; Mammary Neoplasms, Experimental; Methylnitrosourea; Oxidants; Rats; Rats, Sprague-Dawley; Time Factors

Topics: Administration, Oral; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Blood Cell Count; Cells, Cultured; Disease Models, Animal; Drug Therapy, Combination; Epirubicin; Female; Gamma Rays; Hematopoiesis; Injections, Intraperitoneal; Leukopenia; Lung Neoplasms; Macrophages, Peritoneal; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred CBA; Neoplasm Transplantation; Propolis; Radiation-Protective Agents; Solubility; Time Factors

Topics: Animals; Antibiotics, Antineoplastic; Area Under Curve; Chromatography, High Pressure Liquid; Disease Models, Animal; Epirubicin; Hepatic Artery; Injections, Intra-Arterial; Injections, Intravenous; Liver; Liver Failure, Acute; Liver Function Tests; Male; Rats; Rats, Wistar; Tissue Distribution

Topics: Animals; Cold Temperature; Disease Models, Animal; Doxorubicin; Epirubicin; Extravasation of Diagnostic and Therapeutic Materials; Humans; Infusions, Intravenous; Injections, Intravenous; Mice; Swine

Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Electrophysiology; Epirubicin; Heart; Heart Failure; In Vitro Techniques; Isoproterenol; Myocardial Contraction; Myocardium; Rabbits

Topics: Administration, Intravesical; Animals; Antibiotics, Antineoplastic; Carcinogens; Dimethyl Sulfoxide; Disease Models, Animal; Epirubicin; Excipients; Hyperplasia; Male; Methylnitrosourea; Mucous Membrane; Rats; Rats, Wistar; Urinary Bladder; Urinary Bladder Neoplasms